In HCC patients, VEGF expression has been correlated with aggressive behavior, early metastasis spread, vascular invasion, and poor prognosis; in patients undergoing TACE, high serum VEGF levels are predictive of poor tumor response. This evidence concerns the gene VEGFA and hepatocellular carcinoma.